Långängen Pharma AB is a Swedish AB, operating in the Economic activity was not specified by tax authority sector. Incorporated in 2016, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.
Bolaget ska bedriva holdingverksamhet och kapitalförvaltning samt indirekt, via dotterbolag, bedriva verksamhet inom tillverkning och försäljning av läkemedel samt därmed förenlig verksamhet.
(no translation available)
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
In its most recent annual report (2021), Långängen Pharma AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2017 to 2021. The bottom line showed a net profit of SEK 22.4m.
At the end of 2021, equity financed 36.7% of the balance sheet, and current assets covered short-term debt 1.3 times.
Frequently asked questions
What is the Org number of Långängen Pharma AB?
Långängen Pharma AB is registered with Bolagsverket / SCB under Org 5590917992.
Who is the chairman of Långängen Pharma AB?
Anders Leif Håkansson chairs the board of Långängen Pharma AB, in role since 2020.
